HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Marks, J. B. Search for Related Content PubMed Articles by Marks, J. B. Social Bookmarking                What's this?

Is It Time for a Combination Antihyperglycemic-Statin Pill?

The first 20% of the full text of this article appears below.

Cardiovascular disease (CVD) associated with type 2 diabetes is undoubtedly multifactorial, with significant risk attributable to oft-associated conditions hypertension and dyslipidemia and, to an as yet undefined extent, hyperglycemia. However, recently published results from the data analysis of the diabetic subgroup of the Heart Protection Study (HPS),1 summarized by Ronald B. Goldberg, MD, in the "Landmark Studies" department of this issue (p. 151), clearly highlight the tremendous risk for CVD conferred by diabetes regardless of other risk factors.

The nearly 6,000 diabetic individuals in this study are in a category of patients who may . . . [Full Text of this Article]

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?